Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production

Arthritis and Rheumatism

Volumn 60, Issue 5, 2009, Pages 1438-1450

  Couchourel, Denis ^a   Aubry, Isabelle ^a   Delalandre, Aline ^a   Lavigne, Martin ^b   Martel Pelletier, Johanne ^a   Pelletier, Jean Pierre ^a   Lajeunesse, Daniel ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; COLLAGEN TYPE 1A2; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PROSTAGLANDIN E2; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MATRIX; BONE MINERALIZATION; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TIBIA; WESTERN BLOTTING;

AGED; ALKALINE PHOSPHATASE; ANTHRAQUINONES; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE I; COLORING AGENTS; DINOPROSTONE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MALE; OSTEOARTHRITIS; OSTEOBLASTS; OSTEOCALCIN; OSTEOPONTIN; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 66049159060     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24489     Document Type: Article

References (57)

1. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis. Arthritis Rheum 1998;41:891-899 (Pubitemid 28225790)
2. Mansell JP, Bailey AJ. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest 1998;101:1596-1603 (Pubitemid 28198488)
3. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum 1998;40:1282-1291
4. Radin EL, Rose RM. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop 1986;213:34-40. (Pubitemid 17187796)
5. Li B, Aspden RM. Composition and mechanical properties of cancellous bone from the femoral head of patients with osteoporosis or osteoarthritis. J Bone Miner Res 1997;12:641-651 (Pubitemid 27155224)
6. Li B, Aspden RM. Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 1997;56:247-254 (Pubitemid 27239581)
7. Ding M, Danielsen CC, Hvid I. Bone density does not reflect mechanical properties in early-stage arthrosis. Acta Orthop Scand 2001;72:181-185 (Pubitemid 32402334)
8. Ding M, Odgaard A, Hvid I. Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Joint Surg Br 2003;85:906-912 (Pubitemid 36986859)
9. Blair-Levy JM, Watts CE, Fiorientino NM, Dimitriadis EK, Marini JC, Lipsky PE. A type I collagen defect leads to rapidly progressive osteoarthritis in a mouse model. Arthritis Rheum 2008;58:1096-1106
10. Bailey AJ, Sims TJ, Knott L. Phenotypic expression of osteoblast collagen in osteoarthritic bone: production of type I homotrimer. Int J Biochem Cell Biol 2002;34:176-182 (Pubitemid 34112526)
11. Mansell JP, Tarlton JF, Bailey AJ. Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip. Br J Rheumatol 1997;36:16-19 (Pubitemid 27351217)
12. Mkukuma LD, Imrie CT, Skakle JM, Hukins DW, Aspden RM. Thermal stability and structure of cancellous bone mineral from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis 2005;64:222-225 (Pubitemid 40193616)
13. Lajeunesse D, Hilal G, Pelletier JP, Martel-Pelletier J. Subchondral bone morphological and biochemical alterations in osteoarthritis. Osteoarthritis Cartilage 1999;7:321-322 (Pubitemid 29244111)
14. 2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. J Bone Miner Res 2001;16:713-721
15. Hilal G, Martel-Pelletier J, Pelletier JP, Duval N, Lajeunesse D. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts. Arthritis Rheum 1999;42:2112-2122 (Pubitemid 30263594)
16. 2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage 2002;10:491-500.
17. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY, Henrotin YE. Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2005;13:988-997 (Pubitemid 41536131)
18. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY, Henrotin YE. Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes: this effect is mimicked by interleukin-6, -1β and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Cartilage 2005;13:979-987
19. Massicotte F, Fernandes JC, Martel-Pelletier J, Pelletier JP, Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone 2006;38:333-341 (Pubitemid 43255427)
20. Massicotte F, Aubry I, Martel-Pelletier J, Pelletier JP, Fernandes J, Lajeunesse D. Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts. Arthritis Res Ther 2006;8:R177. (Pubitemid 46211014)
21. Hopwood B, Tsykin A, Findlay DM, Fazzalari NL. Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenetic protein signalling. Arthritis Res Ther 2007;9:R100. (Pubitemid 350239076)
22. Paredes Y, Massicotte F, Pelletier JP, Martel-Pelletier J, Laufer S, Lajeunesse D. Study of role of leukotriene B4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition. Arthritis Rheum 2002;46:1804-1812.
23. Altman RD, Asch E, Bloch DA, Bole G, Borenstein D, Brandt KD, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-1049
24. Lajeunesse D, Busque L, Menard P, Brunette MG, Bonny Y. Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis: correction of the phenotype after bone marrow transplant. J Clin Invest 1996;98:1835-1842. (Pubitemid 26359201)
25. Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B. Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner 1991;14:237-250
26. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
27. Neumann K, Dehne T, Endres M, Erggelet C, Kaps C, Ringe J, et al. Chondrogenic differentiation capacity of human mesenchymal progenitor cells derived from subchondral cortico-spongious bone. J Orthop Res 2008;26:1-8.
28. Laemmli UK. Cleavage of structure proteins during assembly of the head of the bacteriophage T4. Nature 1970;227:680-685
29. Research Services Branch. Public domain NIH Image program. http://rsb.info.nih.gov/nih-image/.
30. Gregory CA, Gunn WG, Peister A, Prockop DJ. An alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004;329:77-84. (Pubitemid 38596903)
31. Franceschi RT, Iyer BS, Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994;9:843-854 (Pubitemid 24178067)
32. Chang MK, Raggatt LZ, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol 2008;181:1232-1244
33. Lee MH, Kim YJ, Kim HJ, Park HD, Kang AR, Kyung HM, et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003;278:34387-34394
34. Carlson CS, Loeser RF, Jayo MJ, Weaver DS, Adams MR, Jerome CP. Osteoarthritis in cynomolgus macaques: a primate model of naturally occurring disease. J Orthop Res 1994;12:331-339 (Pubitemid 24181136)
35. Carlson CS, Loeser RF, Purser CB, Gardin JF, Jerome CP. Osteoarthritis in cynomolgus macaques. III. Effects of age, gender, and subchondral bone thickness on the severity of disease. J Bone Miner Res 1996;11:1209-1217
36. Dieppe P, Cushnaghan J, Young P, Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993;52:557-563 (Pubitemid 23246656)
37. Billingham ME, Meijers MH, Mahwinney B, Malcolm A. Spontaneous osteoarthritis in guinea pigs: cartilage degeneration is preceded by loss of subchondral trabecular bone [abstract]. J Rheum Suppl 1996;1:104.
38. Li B, Marshall D, Roe M, Aspden RM. The electron microscope appearance of the subchondral bone plate in the human femoral head in osteoarthritis and osteoporosis. J Anat 1999;195:101-110 (Pubitemid 29378199)
39. Truong LH, Kuliwaba JS, Tsangari H, Fazzalari NL. Differential gene expression of bone anabolic factors and trabecular bone architectural changes in the proximal femoral shaft of primary hip osteoarthritis patients. Arthritis Res Ther 2006;8:R188. (Pubitemid 46211005)
40. Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int 2006;17:319-336
41. Lisignoli G, Toneguzzi S, Piacentini A, Cristino S, Grassi F, Cavallo C, et al. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients. J Cell Physiol 2006;206:78-85.
42. Hay E, Hott M, Graulet AM, Lomri A, Marie PJ. Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation. J Cell Biochem 1999;72:81-93. (Pubitemid 28541483)
43. Yamagiwa H, Endo N, Tokunaga K, Hayami T, Hatano H, Takahashi HE. In vivo bone-forming capacity of human bone marrow-derived stromal cells is stimulated by recombinant human bone morphogenetic protein-2. J Bone Miner Metab 2001;19:20-28
44. Goff LA, Boucher S, Ricupero CL, Fenstermacher S, Swerdel M, Chase LG, et al. Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis. Exp Hematol 2008;36:1354-1369
45. Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy 2008;10:320-330
46. Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, Simmons PJ. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 1999;14:47-56. (Pubitemid 29021603)
47. Martel-Pelletier J, Hilal G, Pelletier JP, Ranger P, Lajeunesse D. Evidence for increased metabolic activity in human osteoarthritic subchondral bone explants [abstract]. Arthritis Rheum 1997 Suppl 9;40:S182.
48. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM. BMP-2-induced osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 2003;309:689-694 (Pubitemid 37083307)
49. Scharstuhl A, Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Inhibition of endogenous TGF-β during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 2002;169:507-514 (Pubitemid 34686173)
50. Van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 2000;8:25-33. (Pubitemid 30032724)
51. Cutroneo KR. How is type I procollagen synthesis regulated at the gene level during tissue fibrosis. J Cell Biochem 2003;90:1-5. (Pubitemid 37052303)
52. Ghosh AK, Mori Y, Dowling E, Varga J. Trichostatin A blocks TGF-β-induced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun 2007;354:420-426 (Pubitemid 46161342)
53. Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression. Mol Pharmacol 2006;69:597-607. (Pubitemid 43121957)
54. Lok CN, Ehrlich HP, White SL, Buttolph TR, Cutroneo KR, Chiu JF. Oligodeoxynucleotide decoy therapy blocks type 1 procollagen transcription and the prolyl hydroxylase β subunit translation. J Cell Biochem 2008;103:1066-1075
55. Falanga V, Zhou L, Yufit T. Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-β1. J Cell Physiol 2002;191:42-50. (Pubitemid 34195216)
56. Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum 2003;48:3118-3129
57. Lajeunesse D, Aoulad Aissa M, Delalandre A, Fernandes J. Increased expression and production of leptin by subchondral osteoblasts from osteoarthritic patients could play a role in cartilage degradation [abstract]. Arthritis Rheum 2005 Suppl 9;52:S44.